Loading...
Loading...
- Nendreon DNDN - up 19% - Reports Q4 EPS of $(0.17) vs $(0.37) Est; Revenue of $74.80M vs $73.59M Est.
- Perion Network PERI - up 13.5% - Reports Q4 2013 Revenue of $31.3M, 47% YoY increase. EBITDA increased 56% YoY reaching $25.5M.
- Revanece Therapeutics RVNC - up 3% - The IPO quiet-period expired Monday and analyst are getting bullish. Analysts at Cowen, Piper Jaffray, and BMO initiated the equivalent of Buy ratings on the stock with $55, $44, and $37 price targets respectively.
- Array BioPharma ARRY - up 2.5% - Issues Clinical Update on ARRY-502 at Asthma at Scientific Meeting, Reports 6.8% Improvement in FEV1 vs. Placebo.
- Odyssey Marine Exploration OMEX - up 8.5% - Selected for recovery of SS Central America Gold.
- NII Holdings NIHD - up 5% - bouncing today following a more than 50 percent decline on Friday on the heels of quarterly results.
- Allied Nevada Gold ANV - up 3% - Benefiting from Gold pop as investors seek safe haven from geopolitical risk in Ukraine. Elsewhere in the sector, Barrick Gold up ~2 percent, Newmont Mining up 3.4 percent, AngloGold up nearly 4 percent, Kinross up 2 percent, Agnico Eagle up 2.4 percent, Eldorado Gold up 3.3 percent.
- AMCOL International ACO - up 4.8% - Minerals Technologies raises bid for AMCOL to $45/share in cash.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in